Denali Therapeutics Inc. (DNLI) at a glance

Denali Therapeutics Inc. (DNLI) is a mid-cap Healthcare company. It trades at $22.11, with a 0% profit margin. It does not pay a dividend. Vestovix scores it 49/100 overall. Its strongest dimension is Momentum (61/100) and its weakest is Income (40/100). Its volatility is roughly in line with the market.

Price

$22.11

Market cap

$3.44B

P/E ratio

n/a

Dividend yield

None

Beta

1.01

52-week range

$12.58 to $27.30